Publié le March 30, 2023
Abstract: Purpose Pathologic complete response (pCR) has prognostic importance and is frequently used as a primary end point, but doubts…
Lire la suite
Publié le February 27, 2023
Strategic partnership to pair long-standing clinical research expertise with a best-in-class RTSM system
Lire la suite
Publié le December 20, 2022
Discover how IDDI biostatistics-driven RTSM helped the Sponsor to avoid serious imbalance between the two randomized arms for the treated…
Lire la suite
Publié le December 19, 2022
Discover how a Sponsor reached the overall balance amongst 2 arms by adding a stratification factor.
Lire la suite
Publié le December 19, 2022
Discover how a Sponsor optimized the drug delivery via IDDI’s Proposition of a Predictive Drug Supply Model. PLEASE FILL IN…
Lire la suite
Publié le December 12, 2022
Randomized controlled trials (RCTs), particularly in phase 3, are the preferred sources of evidence for drug approval and reimbursement decisions….
Lire la suite
Publié le June 29, 2022
Generalized Pairwise Comparisons – GPC Today’s session is focusing on an innovative statistical methodology called Generalized Pairwise Comparisons – or…
Lire la suite
Publié le January 4, 2022
Join IDDI experts to get updated on efficacy assessment in early-phase trials and more! THURSDAY, FEBRUARY 3 – 9:00 –…
Lire la suite
Publié le November 10, 2021
Be updated on different types of Bayesian and frequentist designs that may be used for expansion cohorts in phase 1…
Lire la suite
Publié le November 3, 2021
This webinar was presented by Laurence Collette, MSc, PhD, Principal Statistician, Consulting Services at IDDI at the 5th Annual Next…
Lire la suite